Company Update – AbbVie Inc. (NYSE:ABBV) – European drug trial secrecy case hit by delay

December 05, 2013 at 10:48 AM EST

[Reuters - UK Focus] – * U.S. firms seeking to block release of drug data by EMA * AbbVie (NYSE: ABBV – news) , InterMune (NasdaqGS: ITMN – news) say they defending business . . . → Read More: Company Update – AbbVie Inc. (NYSE:ABBV) – European drug trial secrecy case hit by delay Similar posts: Merck & Co. Inc. (NYSE:MRK) – Germany’s Merck looks for deals to lift U.S. drug sales Update from Uruguay: The consequences of ending bank secrecy with Argentina Boeingâ€™s Double Top: Will the company continue to soar?

AbbVie Inc. (NYSE:ABBV) [Reuters - UK Focus] – * U.S. firms seeking to block release of drug data by EMA * AbbVie (NYSE: ABBV – news) , InterMune (NasdaqGS: ITMN – news) say they defending business secrets LONDON, Dec 5 (Reuters) – A legal case over access to details of clinical trials held by Europe’s drugs regulator – sparked by two U.S. firms wanting to keep their data secret – has been hit by delay after the EU’s top court sent it back to be re-examined by a lower body. The decision leaves in limbo a … [visit site to read more]